Trial Profile
A mulit-centre, long term follow-up, open label trial to assess the efficacy and safety of Cpn10 in subjects with rheumatoid arthritis (Protocol number CBIO2008-01).
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 22 Jun 2016
Price :
$35
*
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors CBio
- 03 Feb 2011 Status changed from recruiting to discontinued as reported by Australian New Zealand Clinical Trials Registry record.
- 03 Feb 2009 New trial record